Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)Dieter Koeberle, G. Bodoky, Karin Ribi et al.|Annals of Oncology|2016Cited by 140
Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non–Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09Oliver Gautschi, Adrian F. Ochsenbein, Nicholas Mach et al.|Clinical Lung Cancer|2015Cited by 15